Stage IVB Prostate Cancer AJCC v8 Clinical Trials in Cambridge, Minnesota

3 studies are recruiting for stage ivb prostate cancer ajcc v8 in Cambridge, Minnesota right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

    This phase II trial studies how well cabozantinib works in combination with nivolumab and ipilimumab in treating patients with rare genitourinary (GU) tumors that has spread from where it first started (primary site) to other places in the body. Cabozantinib may stop the growth of tumor cells by bl…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Cambridge Medical Center, Cambridge, Minnesota
    Locations
    581 in total
    Run by
    National Cancer Institute (NCI)

    See if you can join NCT03866382 on ClinicalTrials.gov

  2. Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

    This randomized phase III trial examines whether lengthening the dosage interval in an adaptive manner for the prostate cancer drug lutetium 177 Lu PSMA RLT improves quality of life without decreasing lifespan when compared to the standard way this medication is given. This study is for patients wi…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Cambridge Medical Center, Cambridge, Minnesota
    Locations
    129 in total
    Run by
    Alliance for Clinical Trials in Oncology

    See if you can join NCT07200830 on ClinicalTrials.gov

  3. Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body

    This phase III trial compares the effect of adding carboplatin to the standard of care chemotherapy drug cabazitaxel versus cabazitaxel alone in treating prostate cancer that keeps growing even when the amount of testosterone in the body is reduced to very low levels (castrate-resistant) and that h…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Cambridge Medical Center, Cambridge, Minnesota
    Locations
    174 in total
    Run by
    SWOG Cancer Research Network

    See if you can join NCT06470243 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.